medigraphic.com
SPANISH

Revista Cubana de Higiene y Epidemiología

ISSN 1561-3003 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 2

<< Back Next >>

Rev Cubana Hig Epidemiol 2016; 54 (2)

Pulmonary disease caused by Mycobacterium chelonae

Díaz LO, Fernández ON, Díaz TM, Crespo DT, Valdés QML
Full text How to cite this article

Language: Spanish
References: 15
Page: 44-52
PDF size: 191.40 Kb.


Key words:

Mycobacterial infection, pulmonary tuberculosis, Mycobacterium chelonae, sputum culture, pharmacological treatment.

ABSTRACT

Introduction: Environmental mycobacteria are organisms broadly distributed in nature, but the diseases they cause are very infrequent. Mycobacterium chelonae is a species from the group of non-pigmented rapidly-growing bacteria causing skin, bone and soft tissue diseases. Pulmonary disease is the least common, and is generally associated to predisposing factors. Its treatment is difficult, due to the high resistance to the antibiotics recommended.
Objective: Describe two cases of infrequent pulmonary infection by Mycobacterium chelonae.
Case presentation: Two cases are presented with a diagnosis of environmental mycobacterial pulmonary infection by Mycobacterium chelonae. Both patients had long febrile periods, coughing, expectoration, difficulty breathing and deterioration of their nutritional status. Case 1 was treated for pulmonary tuberculosis, and both had a history of bronchiectasis. Diagnosis was based on sputum culture supported by imaging techniques in the two cases with fibrocavitary lesions in upper lobes and bronchiectasis. Both patients have undergone several long treatment schemes, but their Mycobacterium chelonae cultures are still positive, and they maintain respiratory symptoms -particularly Case 1-, with deterioration of their overall health status and extensive bilateral lesions.
Conclusions: In the cases presented there was failure of the pharmacological treatment recommended at present, with sustained positive Mycobacterium chelonae sputum cultures. This denotes the complexity of these cases in their pharmacological management, with long, aggressive therapies leading to poor results.


REFERENCES

  1. Catanzaro A, Daley CL, eds. Clinics in Chest Medicine. Lung Disease due to nontuberculous mycobacterial infections. Philadelphia: W.B. Saunders Company; 2002.

  2. French AL, Benator DA, Gordin FM. Nontuberculous mycobacterial infections. Med Clin North Am. 1997;81:361-79.

  3. Antuña AA, Gutiérrez JJ, Garcia JM. Infecciones respiratorias por micobacterias ambientales. Arch. Bronconeumol. 2005;41(4):206-19

  4. Martínez E, Menéndez R, Palasí P, Santos M, López J. Enfermedades por micobacterias ambientales en pacientes con y sin infección por el VIH: características epidemiológicas, clínicas y curso evolutivo. Arch Bronconeumol. 2001;37:281-6.

  5. Caminero JA, Medina MV, Rodríguez de Castro P. Tuberculosis y otras micobacteriosis. En: Caminero JA, Fernández-Fau L, eds. Manual de Neumología y Cirugía Torácica. Cap. 83. Madrid: Editores Médicos; 1998. p. 1389-419.

  6. Caminero JA. Enfermedades producidas por micobacterias ambientales. En: eds. Guía de la tuberculosis para médicos especialistas. París: UICTER; 2003. p. 370-90.

  7. Glassroth J. Pulmonary disease due to Nontuberculous Mycobacteria. Chest. 2008;133:243-51

  8. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. American Thoracic Society Documents. Am J Respir Crit Care Med. 2009 [citado 23 Jun 2013];175:367-16. Disponible en: http://www.atsjournals.or

  9. Kusunoki S, Esaki T. Proposal of Mycobacterium Peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. Abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov. Int J Syst Bacteriol 1992;42:240-5.

  10. Yakrus MA, Hernández SM, Floyd MM, Sikes D, Butler WR, Metchock B. Comparison of methods for identification of Mycobacterium Abscessus and M. chelonae isolates. J. Clin. Microbiol. 2001;39:4103-10.

  11. Valdés F, Cid A. Micobacterias atípicas. Actas Dermosifiliogr. 2004;95(6):331-57.

  12. Tanya E, Franco O, Zamboni DR, Chávez Nazari B, Rosas R. Reporte de un caso: Infección pulmonar por Mycobacterium chelonae. Neumología y Cirugía de Tórax. 2007;66(3):129-33.

  13. Vidal R. Tuberculosis y micobacteriosis. En: Martín P, Ramos G, Sánchez J, ed. Medicina Respiratoria. Madrid: SEPAR; 2006. Sec VII Cap 51. p. 899-921.

  14. Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Resp. Dis. 1993;147:1271-8.

  15. Daley CL, Griffith DE. Pulmonary disease caused by rapidly growing mycobacteria. Clin. Chest Med. 2002;23:623-32.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Hig Epidemiol. 2016;54